PENDARVIS DAVID 4
4 · RESMED INC · Filed Dec 6, 2022
Insider Transaction Report
Form 4
RESMED INCRMD
PENDARVIS DAVID
Sr. VP, General Counsel
Transactions
- Sale
ResMed Common Stock
2022-12-05$229.81/sh−1,500$344,715→ 98,672 total
Footnotes (1)
- [F1]The transaction was conducted under a Rule 10b5-1 plan.